Titan Pharmaceuticals (TTNP) Financials

$4.61

$0.00 (0.00%)

As on 02-Oct-2025 09:30EDT

Market cap

$6 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.01	--	0.00	0.06	1.53	4.84
Cost of Revenue	0.01	0.01	0.11	0.20	0.20	0.47
Gross Profit	0.01	-0.01	0.00	-0.14	1.33	4.37
Operating Expenses	2.61	4.56	7.28	10.30	10.68	11.72
Operating Profit (EBIT)	-2.61	-4.56	-7.28	-10.24	-9.35	-7.35
Other Income	--	--	--	--	--	0.71
Profit before Tax	-2.81	-4.71	-5.57	-10.21	-8.78	-7.41
Provision for Tax	0.04	--	-0.06	-0.03	-0.66	13.32
Profit after Tax (Net Income)	-2.81	-4.71	-5.57	-10.18	-8.11	-20.73
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-8.78	-18.24

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	2.79	2.44	6.64	1.36	5.14	3.53
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	0.07	0.19	0.33
Current Liabilities	0.26	0.48	1.44	2.63	2.67	4.22
Total Liabilities	3.31	2.92	8.09	4.06	7.99	8.09

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	--	--	0.07	0.46	0.77	0.76
Current Assets	3.05	2.92	8.02	3.60	7.23	7.33
Total Assets	3.31	2.92	8.09	4.06	7.99	8.09
Total Debt*	--	--	0.57	0.19	0.30	0.81
Net Current Assets	2.79	2.44	6.57	0.97	4.56	3.11

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-3.88	-7.09	-8.18	-7.90	-17.20
Cash Flow from Investing Activities	--	--	0.73	--	-0.02	-0.54
Cash from Financing Activities	--	-0.06	10.00	4.98	8.84	17.93
Net Cash Inflow / Outflow	--	--	--	--	--	0.19

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-2.98	-5.23	-0.74	-1.38	-4.06	-10.38
Cash EPS ($)	--	-5.23	-0.72	-1.35	-3.95	-10.23
Adjusted Book Value ($)	--	2.71	0.88	0.18	2.57	1.77
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.32	-0.94	-1.11	-3.95	-8.61
Free Cash Flow per Share ($)	--	-4.32	-0.94	-1.11	-3.97	-8.88

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-97.56	-127.19	-291.31	-165.96	-405.83
ROE (%)	-107.31	-103.63	-139.14	-313.09	-187.17	-834.96
ROA (%)	-69.95	-85.49	-91.72	-168.88	-100.91	-235.43
EBIT Margin (%)	-26,060.00	--	-727,700.00	-17,058.33	-612.98	-151.94
Net Margin (%)	-28,050.00	--	-556,900.00	-16,961.67	-531.72	-373.41
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-88.24	-1.00	-0.98	-0.96	-0.68	0.34
EBIT Growth (%)	63.45	35.33	28.90	-9.42	-27.25	-12.69
Net Profit Growth (%)	48.64	15.50	45.28	-25.43	60.85	-28.83
EPS Growth (%)	-8.94	-6.08	0.46	0.66	0.61	-0.78
Book Value Growth (%)	-40.09	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.62	-0.55	-0.57	-0.25	-0.32
Price / Book Value	2.20	1.20	0.47	4.25	0.40	1.86
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.92	-0.02	0.43	-0.30	0.41	-0.28
Close Price ($)	4.20	3.26	8.20	15.66	20.40	65.80
High Price ($)	14.80	187.04	21.80	31.80	92.20	327.00
Low Price ($)	3.03	3.12	5.00	6.99	19.60	56.40
Market Cap ($ Cr)	6.13	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	--	0.09	0.14	0.06	0.23
Short term debt to equity ratio	--	--	0.09	0.18	0.04	0.18
Current Ratio	11.60	6.05	5.55	1.37	2.71	1.74
Quick Ratio	11.60	--	5.55	1.33	2.60	1.66
Interest Coverage	--	--	--	-352.93	-9,354.00	-9.56

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	1,430.00	--	104,600.00	60.00	7.34	18.27
Asset Turnover	0.00	--	0.00	0.01	0.19	0.55
Receivable days	--	--	197,600.25	450.48	119.20	49.90
Inventory Days	--	--	172.84	371.77	569.90	513.05
Payable days	--	20,088.75	1,700.70	1,388.32	1,879.48	800.15
Cash Conversion Cycle	--	--	196,072.40	-566.08	-1,190.38	-237.19

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.